Similarly, the Fgfr2cC342Y mutation is one of the more strongly activating mutations of Fgfr2 causing craniosynostosis, being ligand-independent and generating a higher basal level of phospho-ERK compared to, for example, Apert syndrome mutations [35]. Here, FGFR2 is linked to Apert syndrome.